A Study of Atezolizumab Administered Alone or in Combination With Azacitidine in Participants With Myelodysplastic Syndromes
Clinical trial NCT02508870 · COMPLETED
Trial details
- NCT number
- NCT02508870
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-30
- Primary completion
- 2019-06-10
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.